Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Hepatitis C

  Free Subscription


1 Enferm Infecc Microbiol Clin
1 Gastroenterology
1 Haemophilia
4 Hepatology
4 J Med Virol
3 J Virol
2 PLoS One
1 Transfusion

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Enferm Infecc Microbiol Clin

  1. ALVAREZ PAREDES L, Buzon Martin L, Ortega Lafont M, Moran Rodriguez MA, et al
    Spontaneous bacterial peritonitis due to Helicobacter pylori in a cirrhotic patient with human immunodeficiency virus and hepatitis C virus coinfection.
    Enferm Infecc Microbiol Clin. 2018 Feb 8. pii: S0213-005X(17)30389.
    PubMed     Text format    


  2. MA AT, Feld JJ
    Hepatitis B Reactivation With Hepatitis C Treatment: Bringing Some Clarity to the Black Box.
    Gastroenterology. 2018 Feb 6. pii: S0016-5085(18)30161.
    PubMed     Text format    


  3. GIOULEME O, Paschos P, Katsoula A, Panteliadou K, et al
    Hepatitis C infection in a Greek population with inherited bleeding disorders.
    Haemophilia. 2018 Feb 13. doi: 10.1111/hae.13427.
    PubMed     Text format    


  4. KWON YC, Meyer K, Peng G, Chatterjee S, et al
    Hepatitis C virus E2 envelope glycoprotein induces an immunoregulatory phenotype in macrophages.
    Hepatology. 2018 Feb 14. doi: 10.1002/hep.29843.
    PubMed     Text format     Abstract available

  5. DOI A, Hikita H, Sakamori R, Tahata Y, et al
    NS5A-P32 deletion after failure of ledipasvir/sofosbuvir in hepatitis C virus genotype 1b infection.
    Hepatology. 2018 Feb 9. doi: 10.1002/hep.29836.
    PubMed     Text format    

  6. SMITH D, Magri A, Bonsall D, Ip CL, et al
    Resistance analysis of genotype 3 HCV indicates subtypes inherently resistant to NS5A inhibitors.
    Hepatology. 2018 Feb 9. doi: 10.1002/hep.29837.
    PubMed     Text format     Abstract available

  7. ROSEN HR, Ghany M, Chung R, Lok A, et al
    NAM 2017 Report: A National Plan To Eliminate Hepatitis B and C In the United States By 2030 And The AASLD's Response.
    Hepatology. 2017 Jul 17. doi: 10.1002/hep.29361.
    PubMed     Text format    

    J Med Virol

  8. HUNDIE GB, Raj VS, Gebre Michael D, Haagmans BL, et al
    Seroepidemiology of hepatitis B and C virus infections among blood donors in Ethiopia.
    J Med Virol. 2017 Jan 25. doi: 10.1002/jmv.24770.
    PubMed     Text format     Abstract available

  9. GRANDAL M, Pernas B, Tabernilla A, Marino A, et al
    Prevalence of NS5A Resistance Associated Substitutions in patients with hepatitis C virus genotypes 1a and 3: Impact on Current Therapeutic Strategies.
    J Med Virol. 2018 Feb 10. doi: 10.1002/jmv.25048.
    PubMed     Text format     Abstract available

  10. OGATA F, Akuta N, Kobayashi M, Fujiyama S, et al
    Amino Acid Substitutions in the Hepatitis C Virus Core Region Predict Hepatocarcinogenesis Following Eradication of HCV RNA by All-Oral Direct-Acting Antiviral Regimens.
    J Med Virol. 2018 Feb 10. doi: 10.1002/jmv.25047.
    PubMed     Text format     Abstract available

  11. RAN M, Huang J, Liang H, Jiang J, et al
    Alcohol attenuates anti-HCV function of IFN-lambda1 through up-regulation of PLASy expression in human hepatic cells.
    J Med Virol. 2018 Feb 15. doi: 10.1002/jmv.25053.
    PubMed     Text format     Abstract available

    J Virol

  12. MOUSTAFA S, Karakasiliotis I, Mavromara P
    Hepatitis C virus core+1/ARFP modulates Cyclin D1/pRb pathway and promotes carcinogenesis.
    J Virol. 2018 Feb 14. pii: JVI.02036-17. doi: 10.1128/JVI.02036.
    PubMed     Text format     Abstract available

  13. SHIMIZU Y, Shirasago Y, Kondoh M, Suzuki T, et al
    Monoclonal antibodies against occludin completely prevented hepatitis C virus infection in a mouse model.
    J Virol. 2018 Feb 7. pii: JVI.02258-17. doi: 10.1128/JVI.02258.
    PubMed     Text format     Abstract available

  14. WIJESUNDARA DK, Gummow J, Li Y, Yu W, et al
    Induction of genotype-cross reactive, hepatitis C virus-specific cell mediated immunity in DNA-vaccinated mice.
    J Virol. 2018 Feb 7. pii: JVI.02133-17. doi: 10.1128/JVI.02133.
    PubMed     Text format     Abstract available

    PLoS One

  15. KELLY ML, Riordan SM, Bopage R, Lloyd AR, et al
    Capacity of non-invasive hepatic fibrosis algorithms to replace transient elastography to exclude cirrhosis in people with hepatitis C virus infection: A multi-centre observational study.
    PLoS One. 2018;13:e0192763.
    PubMed     Text format     Abstract available

  16. ANADOL E, Lust K, Boesecke C, Schwarze-Zander C, et al
    Exposure to previous cART is associated with significant liver fibrosis and cirrhosis in human immunodeficiency virus-infected patients.
    PLoS One. 2018;13:e0191118.
    PubMed     Text format     Abstract available


  17. SHAN Z, Huang J, Liao Q, Huang K, et al
    Association of killer cell immunoglobulin-like receptors with spontaneous clearance of hepatitis C virus in the Chinese population.
    Transfusion. 2018 Feb 15. doi: 10.1111/trf.14527.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.